Peng Lu - 18 Jun 2026 Form 4 Insider Report for Pharvaris N.V. (PHVS)

Reporting relationship: Chief Medical Officer
Issuer ticker: PHVS
Reported as of: 18 Jun 2026
Net transaction value: -$10,200
SEC form: 4
Accepted by SEC: 23 Jun 2026, 17:07:28 UTC
Prior SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Marnus Nel, Attorney-in-Fact for Peng Lu

Key filing fact

Peng Lu filed Form 4 for Pharvaris N.V. (PHVS) on 23 Jun 2026.

Key facts

This page summarizes Peng Lu's Form 4 filing for Pharvaris N.V. (PHVS).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Jun 2026, 17:07.

Change

Previous filing in this sequence was filed on 16 Jun 2026.
Current net transaction value: -$10,200.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001972159 Primary reporting owner

Lu Peng

Relationship: Chief Medical Officer
Address: 1 CRANBERRY HILL SUITE 400, LEXINGTON
Signature: /s/ Marnus Nel, Attorney-in-Fact for Peng Lu
Signature date: 23 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHVS transaction

Common Stock

Options Exercise

Transaction value
Shares: +300
Change %: +0.46%
Price: $2.59^*
Shares after: 65,931
Date: 18 Jun 2026
Ownership: Direct
Footnotes: F1

PHVS transaction

Common Stock

Sale

Transaction value: $10,200
Shares: -300
Change %: -0.46%
Price: $34.00
Shares after: 65,631
Date: 18 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHVS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -300
Change %: -0.15%
Price: $0.000000^*
Shares after: 205,008
Date: 18 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 245,308
Exercise price: $2.59
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

This is a scheduled exercise and sale from 10b5-1 trading plan.

Footnote F2

25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.